Journal of Diseases
ISSN: Coming Soon
Current Issue
Volume No: 1 Issue No: 1
share this page

Editorial | Open Access
  • Available online freely | Peer Reviewed
  • Journal of Diseases

    Sandra Grumelli 1      

    1CIMER Universidad Catolica of Cordoba, Argentina

    Received 12 Mar 2018; Accepted 12 Mar 2018; Published 19 Mar 2018;

    Copyright©  2018 Sandra Grumelli, et al

    License
    Creative Commons License    This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    Competing interests

    The authors have declared that no competing interests exist.

    Citation:

    Sandra Grumelli (2018) Journal of Diseases . Journal of Diseases - 1(1):1-1.
    Download as RIS, BibTeX, Text (Include abstract )
    DOIComing Soon

    Introduction:



    From the Journal of Disease, we recognize that studies of diseases have greatly contributed to the understanding of the intricacies of the biochemistry of the normal human body physiology. An example of this process is appreciated in the studies of Chronic Obstructive Pulmonary Disease (COPD), where at its beginning was treated as asthma. However, the basic research on immune cells from diseased tissue was central to understand not only the mechanism of the disease but also the regulation of the immune system which was mostly researched by studies of patients with human immunodeficiency virus (HIV). This disease has the particularity to make evident how after the immune system has been triggered, by an injury or toxic like cigarette smoke, it may derive to different diseases like cancer or emphysema. It has been reported that only 0.8 to 1.7% of COPD patients develops cancer1, 2 and a maximum of 8.6% incidence has been reported3, while 27% of HIV patients have COPD4, suggesting a mechanism orthogonal of disease progression between cancer and emphysema.

    What are the determinants to the disease outcome after smoke exposure? is it genetics? gene regulation or epigenic? intensity of the exposure to smoke or infections? The answers to these questions would give a better insight of the immune system regulation after it has been activated and cleared the injury.

    This is why studying the diseased state is so important for understanding the functioning in health and how to restore it once it has been lost.

    References

    1.Tockman M S, Anthonisen N R, Wright E C. (1987) Airways obstruction and the risk for lung cancer. , Ann Intern Med1987; 106, 512-518.
    2.Vineis P, Airoldi L, Veglia F.Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study,BMJ2005;. 330-277.
    3.De Torres JP, Maron J M, Casanova C.Lung cancer in patients with chronic obstructive pulmonary disease: incidence and predicting factors. , Am J Respir Crit Care Med2011; 184, 913-919.
    4.Drummond M B, Huang L, Diaz P T. (2015) Factors associated with abnormal spirometry among HIV-infected individuals. , AIDS; 29(13), 1691-1700.